Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02205359 · ClinicalTrials.gov registry record · NA
AdaptResponse Clinical Trial
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 3,797
- Enrollment target
NCT02205359 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 3,797 participants.
The verdict
NCT02205359, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,797 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).
Interventions
- DEVICE aCRT ON
- DEVICE aCRT OFF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,797 participants |
| Start Date | 2014-08 |
| Est. Completion | 2022-11-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02205359
The ClinicalTrials.gov registry entry for NCT02205359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,797 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which aCRT ON is the first listed.
NCT02205359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02205359 about?
NCT02205359 is a clinical study titled "AdaptResponse Clinical Trial". The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) condu...
What is the current status of trial NCT02205359?
This trial is currently completed. It is a NA study. The enrollment target is 3,797 participants. The study started on 2014-08. Estimated completion is 2022-11-02.
What interventions are being tested in trial NCT02205359?
The interventions under investigation include: aCRT ON (DEVICE), aCRT OFF (DEVICE).
Who is sponsoring clinical trial NCT02205359?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.